Maria D. Setzu
Cagliari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Restoring brain wiring, mobility, sleep, and lifespan with a novel repurposed modulator of voltage-gated K+ channels: an emerging perspective for channelopathies.
Journal: Journal of translational medicine
Published: October 16, 2025
Restoring brain wiring, mobility, sleep, and lifespan with a novel repurposed modulator of voltage-gated K+ channels: an emerging perspective for channelopathies.
Journal: Journal of translational medicine
Published: October 16, 2025
Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C2-Symmetric Dimer in a Drosophila Model of Parkinson's Disease.
Journal: Biomolecules
Published: December 21, 2023
An activator of voltage-gated K+ channels Kv1.1 as a therapeutic candidate for episodic ataxia type 1.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 24, 2023
Effects of memantine on mania-like phenotypes exhibited by Drosophila Shaker mutants.
Journal: CNS neuroscience & therapeutics
Published: November 16, 2022
SmartFlareTM is a reliable method for assessing mRNA expression in single neural stem cells.
Journal: World journal of stem cells
Published: June 18, 2021
Improvements of Motor Performances in the Drosophila LRRK2 Loss-of-Function Model of Parkinson's Disease: Effects of Dialyzed Leucocyte Extracts from Human Serum.
Journal: Brain sciences
Published: December 07, 2019
Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson's Disease.
Journal: Frontiers in aging neuroscience
Published: November 20, 2019
Standardized phytotherapic extracts rescue anomalous locomotion and electrophysiological responses of TDP-43 Drosophila melanogaster model of ALS.
Journal: Scientific reports
Published: February 23, 2018
Functional and Morphological Correlates in the Drosophila LRRK2 loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) Administration.
Journal: PloS one
Published: September 25, 2015
Last Updated: 09/26/2026